These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31347924)

  • 41. The current status and prospects of antibody engineering for therapeutic use: focus on glycoengineering technology.
    Niwa R; Satoh M
    J Pharm Sci; 2015 Mar; 104(3):930-41. PubMed ID: 25583555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibodies.
    Ackermann R
    Hum Cell; 1988 Mar; 1(1):46-53. PubMed ID: 3154013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production, novel assay development and clinical applications of monoclonal antibodies.
    Chiarella P
    Recent Pat Anticancer Drug Discov; 2011 May; 6(2):258-67. PubMed ID: 21247405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Expectations from the use of monoclonal antibodies].
    Garza Ramos J
    Salud Publica Mex; 1985; 27(3):260-5. PubMed ID: 3901317
    [No Abstract]   [Full Text] [Related]  

  • 45. [Monoclonal antibodies].
    Bulycheva TI; Lenskaia RV
    Gematol Transfuziol; 1990 Apr; 35(4):3-4. PubMed ID: 2373346
    [No Abstract]   [Full Text] [Related]  

  • 46. Antibody-based immunotherapy in high-risk neuroblastoma.
    Johnson E; Dean SM; Sondel PM
    Expert Rev Mol Med; 2007 Dec; 9(34):1-21. PubMed ID: 18081947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel monoclonal antibody specific for cocaine.
    Nakayama H; Kenjyou N; Shigetoh N
    Monoclon Antib Immunodiagn Immunother; 2013 Aug; 32(4):262-4. PubMed ID: 23909419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of monoclonal antibodies in the miniPERM bioreactor: comparison with other hybridoma culture methods.
    Falkenberg FW
    Res Immunol; 1998; 149(6):560-70. PubMed ID: 9835419
    [No Abstract]   [Full Text] [Related]  

  • 49. Monoclonal antibody drug immunoconjugates for targeted treatment of cancer.
    Trail PA; King HD; Dubowchik GM
    Cancer Immunol Immunother; 2003 May; 52(5):328-37. PubMed ID: 12700948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hybridoma-produced monoclonal antibodies: the most revolutionary technique in immunobiology (author's transl)].
    Ruiz-Argüelles A
    Rev Invest Clin; 1982; 34(1):79-84. PubMed ID: 7046001
    [No Abstract]   [Full Text] [Related]  

  • 51. CRISPR/Cas9-Mediated Genetic Engineering of Hybridomas for Creation of Antibodies that Allow for Site-Specific Conjugation.
    Khoshnejad M; Brenner JS; Parhiz H; Muzykantov VR
    Methods Mol Biol; 2019; 2033():81-93. PubMed ID: 31332749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoclonal antibodies in therapy of solid tumors.
    Heimann DM; Weiner LM
    Surg Oncol Clin N Am; 2007 Oct; 16(4):775-92, viii. PubMed ID: 18022544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of an anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation.
    Rycyzyn MA; Staquet K; Fisher J; Bannish G; Bassiri A; Duchala C; Giles-Komar J
    Hybridoma (Larchmt); 2008 Feb; 27(1):25-30. PubMed ID: 18294073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proceedings of the Eleventh Conference on Cancer Therapy with Antibodies and Immunoconjugates. October 12-14, 2006. Parsippany, New Jersey, USA.
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5499s-660s. PubMed ID: 18080348
    [No Abstract]   [Full Text] [Related]  

  • 57. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.
    Parren PW; Burton DR; Bradbury A; Huston JS; Carter PJ; Veldman T; Chester KA; Larrick JW; Alfenito MR; Scott JK; Weiner LM; Adams GP; Reichert JM
    MAbs; 2015; 7(6):981-8. PubMed ID: 26421752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant antibodies for cancer therapy.
    Deonarain MP
    Expert Opin Biol Ther; 2008 Aug; 8(8):1123-41. PubMed ID: 18613764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.